Screener
Summit Therapeutics SMMT Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Summit Therapeutics’s reported figures.
The source filing: Summit Therapeutics’s 10-Q, filed April 30, 2026. Open the filing →
- Filed
- Apr 30, 2026, 5:00 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001599298-26-000039
FAQ
- What is Summit Therapeutics's enterprise value?
- Summit Therapeutics (SMMT) reported enterprise value of $14.71B in Q1 2026.
- How has Summit Therapeutics's enterprise value changed year-over-year?
- Summit Therapeutics's enterprise value increased by 3.4% year-over-year, from $14.23B to $14.71B.
- What is the long-term trend for Summit Therapeutics's enterprise value?
- Over 5 years (2020 to 2025), Summit Therapeutics's enterprise value has grown at a 32.1% compound annual growth rate (CAGR), from $3.23B to $13.02B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Summit Therapeutics's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude